ELN Treat. Research Quality of Life and Late Effects Internal Workshops  · 

Created by: Ihrig , generated 2010/02/25 , last changed: 2010/03/02

ELIC has organized a first ELN workshop on a major cross-sectional scientific issue for the different disease related workpackages: Quality of Life and Late Effects in Hematolgocial Malignancies (Feb 2010). The idea of the workshop was to inform about current and planned activities in the ELN and to improve collaboration and initiate joint projects.

Presentations

CML

Quality of Life in CML patients (35KB)

Quality of Life in CML patients - Projects of the German CML Study Group
Dr. Ute Kossak, Dr. Susanne Saußele

Second malignancies in CML (368KB)

Second malignancies in CML treated with tyrosine kinase inhibitors in the Czech Republic and Slovakia
Voglová J., Mužík J., Faber E., Žáčková D., Klamová H., Doubek M., Steinerová K., Michalovičová Z., Demitrovičová L., Cmunt E., Nováková E., Tóthová E., Mayer J., Indrák K.

MDS

Quality of Life in Myelodysplasticsyndrome Patients (1.2 MB)

Quality of Life in Myelodysplasticsyndrome Patients:What have we learned so far?
Fabio Efficace, PhD

Home versus Hospital Chemotherapy (274KB)

Home versus Hospital Chemotherapy in MDS or MM : Preliminary results on QoL
Prof. Odile BEYNE-RAUZY, MD, PhD